HEXADROL (dexamethasone sodium phosphate) by Aspen Surgical is clinical pharmacology naturally occurring glucocorticoids, (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. First approved in 1964.
Drug data last refreshed 20h ago
HEXADROL (dexamethasone sodium phosphate) is a potent synthetic glucocorticoid administered by injection for systemic anti-inflammatory and immunomodulatory effects. It treats diverse conditions including ataxia telangiectasia, peripheral arterial disease, atopic keratoconjunctivitis, and perioperative inflammation by blocking inflammatory cytokine production and modifying immune responses. Unlike natural glucocorticoids, dexamethasone lacks significant sodium-retaining properties, making it suitable for prolonged anti-inflammatory therapy.
As loss of exclusivity approaches, the HEXADROL brand team likely faces portfolio consolidation pressure and may shift focus toward lifecycle management and cost optimization rather than growth initiatives.
CLINICAL PHARMACOLOGY Naturally occurring glucocorticoids, (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs, including dexamethasone, are primarily used for their potent…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients
Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients
Worked on HEXADROL at Aspen Surgical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
HEXADROL offers limited career growth potential given its approaching loss of exclusivity and mature, commodity-like market position. Roles are primarily commercial and defensive in nature, focused on pricing, access, and retention rather than innovation or brand building.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo